R386-900-3. Definitions  


Latest version.
  •   The following definitions apply to this rule:

      (1) "Department" means the Utah Department of Health Bureau of Epidemiology Prevention, Treatment and Care Program.

      (2) "Syringe exchange" is defined in 26-7-8.

      (3) "Operating entity" is defined in 26-7-8.

      (4) "HIV" human immunodeficiency virus.

      (5) "HCV" hepatitis C virus.

      (6) "HBV" hepatitis B virus.

      (7) "Opiate antagonist" is defined by Chapter 55, Opiate Overdose Response Act.